← Leaderboards
Heather S.l. Jim
H. Lee Moffitt Cancer Ctr & Res Inst
$14,608,363
Attributed
$19,450,633
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,450,633 · 10
By mechanism
R01$15,164,297 · 5
R21$2,786,574 · 2
K07$712,800 · 1
R34$627,562 · 1
R03$159,400 · 1
Top collaborators
- Eida Maria Castro5 shared
- Jane C. Figueiredo5 shared
- Frederick Locke5 shared
- Brent John Small5 shared
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- Frederick Locke$1,743,048
- Thomas H. Brandon$14,530,397
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsBiologicalFatigueQuality Of LifeCancer PatientBehaviorPatient Self-ReportParticipantAffectSamplingReportingSymptomsMental DepressionFutureChemotherapyPathway InteractionsInnovationEvaluationPhysical ActivityInflammationRecruitGenesCancer CenterSleep
Grant awards (40)
Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison$770,748
R01 · FY2025 · CA · contact PI
Adaptation and Preliminary Evaluation of Energize-MBC: Cognitive Behavioral Therapy for Fatigue among Women with Metastatic Breast Cancer$308,399
R34 · FY2025 · CA · contact PI
Novel Biomarkers for Cancer-Related Fatigue: Integrating Metabolomics, Genomics and Behaviors$659,219
R01 · FY2024 · NR
Adaptation and Preliminary Evaluation of Energize-MBC: Cognitive Behavioral Therapy for Fatigue among Women with Metastatic Breast Cancer$319,163
R34 · FY2024 · CA · contact PI
Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison$160,118
R01 · FY2024 · CA · contact PI
Novel Biomarkers for Cancer-Related Fatigue: Integrating Metabolomics, Genomics and Behaviors$661,957
R01 · FY2023 · NR
Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison$657,991
R01 · FY2023 · CA · contact PI
Accelerated aging after chimeric antigen receptor T-cell therapy (CART): Leveraging a novel population of cancer survivors to elucidate mechanisms of dementia$470,597
R01 · FY2023 · CA · contact PI
Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison$707,291
R01 · FY2022 · CA · contact PI
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the Microbiome$677,991
R01 · FY2022 · CA · contact PI
Novel Biomarkers for Cancer-Related Fatigue: Integrating Metabolomics, Genomics and Behaviors$664,970
R01 · FY2022 · NR
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue$590,368
R01 · FY2022 · CA · contact PI
Post-Hurricane Cancer Care: Patient Needs after Hurricane Maria$509,208
R21 · FY2022 · MD
Epidemiologic Intelligence Network (EpI-Net) to promote COVID-19 testing and prevention practices among socially vulnerable communities in Puerto Rico$1,427,381
R21 · FY2021 · MD
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the Microbiome$683,538
R01 · FY2021 · CA · contact PI
Novel Biomarkers for Cancer-Related Fatigue: Integrating Metabolomics, Genomics and Behaviors$676,985
R01 · FY2021 · NR
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue$582,688
R01 · FY2021 · CA · contact PI
Novel Biomarkers for Cancer-Related Fatigue: Integrating Metabolomics, Genomics and Behaviors$734,278
R01 · FY2020 · NR
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the Microbiome$684,103
R01 · FY2020 · CA · contact PI
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue$583,491
R01 · FY2020 · CA · contact PI
Post-Hurricane Cancer Care: Patient Needs after Hurricane Maria$212,707
R21 · FY2020 · MD
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue$714,661
R01 · FY2019 · CA · contact PI
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the Microbiome$664,153
R01 · FY2019 · CA · contact PI
Post-Hurricane Cancer Care: Patient Needs after Hurricane Maria$200,863
R21 · FY2019 · MD
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the Microbiome$800,562
R01 · FY2018 · CA · contact PI
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue$495,885
R01 · FY2018 · CA · contact PI
Post-Hurricane Cancer Care: Patient Needs after Hurricane Maria$247,978
R21 · FY2018 · MD
Sickness Behaviors in Gynecologic Cancer Patients Treated with Chemotherapy$509,011
R01 · FY2016 · CA · contact PI
Internet-Assisted Cognitive Behavior Intervention for Targeted Therapy Fatigue$188,437
R21 · FY2016 · CA · contact PI
Sickness Behaviors in Gynecologic Cancer Patients Treated with Chemotherapy$503,416
R01 · FY2015 · CA · contact PI
Sickness Behaviors in Gynecologic Cancer Patients Treated with Chemotherapy$488,314
R01 · FY2014 · CA · contact PI
Sickness Behaviors in Gynecologic Cancer Patients Treated with Chemotherapy$476,446
R01 · FY2013 · CA · contact PI
Genetic Predictors of Cognitive Function, Depression and Fatigue in Cancer$131,763
K07 · FY2013 · CA · contact PI
Sickness Behaviors in Gynecologic Cancer Patients Treated with Chemotherapy$545,516
R01 · FY2012 · CA · contact PI
Genetic Predictors of Cognitive Function, Depression and Fatigue in Cancer$132,355
K07 · FY2012 · CA · contact PI
Genetic Predictors of Cognitive Function, Depression and Fatigue in Cancer$153,040
K07 · FY2011 · CA · contact PI
Genetic Predictors of Cognitive Function, Depression and Fatigue in Cancer$149,527
K07 · FY2010 · CA · contact PI
Genetic Predictors of Cognitive Function, Depression and Fatigue in Cancer$146,115
K07 · FY2009 · CA · contact PI
Symptom Measurement and Interrelationships During Chemotherapy for Ovarian Cancer$83,000
R03 · FY2008 · CA · contact PI
Symptom Measurement and Interrelationships During Chemotherapy for Ovarian Cancer$76,400
R03 · FY2007 · CA · contact PI